Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia

PHASE2RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic CholecystitisBiliary Dyskinesia
Interventions
DRUG

4-MUST

128 mg of trimebutine 4-methylumbelliferyl sulfate tablet.

DRUG

Placebo

Placebo tablet.

Trial Locations (17)

19119

RECRUITING

"Limited Liability Company Medical Center Eco-Safety", Saint Petersburg

117556

RECRUITING

"State Budgetary Institution of Healthcare of Moscow City Polyclinic No. 2 of the Moscow Department of Healthcare", Moscow

119571

RECRUITING

Unimed-C Jsc, Moscow

153025

RECRUITING

Ivanovo Kuvaev Clinical Hospital, Ivanovo

194156

RECRUITING

"Limited Liability Company Energy of Health", Saint Petersburg

194358

RECRUITING

"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 117", Saint Petersburg

196158

RECRUITING

"Limited Liability Company Clinic Zvezdnaya", Saint Petersburg

199406

RECRUITING

"Limited Liability Company Meili", Saint Petersburg

413116

RECRUITING

"State autonomous health care institution Engels City Clinical Hospital No. 1", Engel's

614070

RECRUITING

Professors' Clinic LLC., Perm

Unknown

RECRUITING

"The State Budgetary Healthcare Institution of the Moscow Region Moscow Regional Research Clinical Institute named after M.F. Vladimirsky", Moscow

RECRUITING

"Limited Liability Company ErSi Medical", Novosibirsk

RECRUITING

"State Budgetary Institution St. Petersburg Research Institute of Emergency Care named after I.I. Djanelidze", Saint Petersburg

RECRUITING

"Private institution of higher education Medical University 'Reavis'", Samara

RECRUITING

"Association Regional Medical Center 'Open Medicine'", Tolyatti

RECRUITING

"LLC Polyclinic Polimedika Veliky Novgorod", Veliky Novgorod

RECRUITING

"Limited Liability Company Medical Center for Diagnosis and Prevention Plus", Yaroslavl

All Listed Sponsors
lead

Valenta Pharm JSC

INDUSTRY